SEC Form D · Amendment · filed November 15, 2017
Araim Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Ann Dunne · Tarrytown, NYExec · DirectorAnthony Cerami · Tarrytown, NYDirectorMichael Brines · Tarrytown, NYExec · DirectorRita Kirk · Tarrytown, NYExecJohn Macomber · Tarrytown, NYDirectorSidney Strickland · Tarrytown, NYDirectorGerald Bernstein · Tarrytown, NYDirectorFerry Breedveld · Tarrytown, NYDirectorWalid J. Abboud · Gatineau, Quebec, CanadaDirectorJonas Schaefer · Belvedere, CADirectorLawrence J. Cannon · Gatineau, Quebec, CanadaDirectorSteve Simon · BOULDER, CODirectorLeonard Nannarone · Scituate, MADirectorLyndon Lien · San Bruno, CAExec · DirectorDavid B. Miller · Dallas, TXExec · DirectorPeter E. Carlton · San Bruno, CAExec · DirectorGary R. Petersen · Houston, TXExecJames Pekarsky · Menlo Park, CAExec · DirectorJohn G. Khabbaz · NEW YORK, NYDirectorAndres G. Garcia · Monterrey Nuevo Leon, O5DirectorVladimir Podlipskiy · Studio City, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗